Tradestie Institutional Equity Comparison Engine

EXOZ vs BUDA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BUDA Overall Edge

BUDA Captures Institutional Edge (2โ€“1 Pillars ยท 1โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BUDA (BUDA) driven by superior Momentum & Technical, Options & Structure while EXOZ counters with relative strength in Growth & Margin. Fundamentally, EXOZ trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus BUDA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, EXOZ sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against BUDA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EXOZ N/M vs BUDA N/M Fwd P/E
Growth & Margin Winner EXOZ
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner BUDA
1Y -81.0% vs -34.6% ยท 52W Pos 1% vs 1%
Options & Structure Winner BUDA
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
EXOZ NASDAQ
eXoZymes Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$2.90
-14.05% 1D
Market Cap $31.9M
1M Return -25.51%
1Y Return -80.96%
Forward P/E N/M
Unified AI Score
42.3 / 100 HOLD
Tech 25.0 Fund 51.0 Flow 50.0 Mom 59.0
BUDA US Equity
BUDA
Institutional Equity
$5.30
-0.19% 1D
Market Cap N/A
1M Return -20.9%
1Y Return -34.65%
Forward P/E N/M
Unified AI Score
34.2 / 100 SELL
Tech 35.0 Fund 42.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EXOZ -80.96% BUDA -34.65% Spread: +35.34 pp (BUDA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EXOZ TTM Op. Margin: 0.0% BUDA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EXOZ vs BUDA. Trailing 12-month operating profitability (EXOZ 0.0% vs BUDA N/A) and valuation multiples (EXOZ N/M vs BUDA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EXOZ (6) vs BUDA (1)
Institutional Metric EXOZ BUDA Criterion Row Winner
Market Capitalization Scale $31.9M N/A Larger Scale EXOZ
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth EXOZ
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin EXOZ
Net Profit Margin Profitability 0.0% N/A Higher Margin EXOZ
Return on Equity (ROE) Capital Efficiency -187.2% N/A Higher ROE EXOZ
52-Week Range Position Momentum 1% ($3โ€“$17) 1% ($5โ€“$12) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 109% Vol -0.03ฮฒ ยท 71% Vol Lower Realized Risk BUDA
Unified Institutional Score Composite Signal 42.3 / 100 (HOLD) 34.2 / 100 (SELL) Higher Composite EXOZ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EXOZ vs BUDA Buy Guide
EXOZ BREAKDOWN
57d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EXOZ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BUDA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BUDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EXOZ nor BUDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.